FDA Inspection 1241469 — Ktut Wiradjaja Arya, MD

Ktut Wiradjaja Arya, MD — FEI 3030430439

The FDA completed an inspection of Ktut Wiradjaja Arya, MD on Apr 26, 2024 in Maroubra. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Apr 26, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
Maroubra (Australia)

Additional Details

Clinical Investigator (CI)